[go: up one dir, main page]

MX2011012069A - Micro-organismos no-replicantes y su efecto inmuno estimulador. - Google Patents

Micro-organismos no-replicantes y su efecto inmuno estimulador.

Info

Publication number
MX2011012069A
MX2011012069A MX2011012069A MX2011012069A MX2011012069A MX 2011012069 A MX2011012069 A MX 2011012069A MX 2011012069 A MX2011012069 A MX 2011012069A MX 2011012069 A MX2011012069 A MX 2011012069A MX 2011012069 A MX2011012069 A MX 2011012069A
Authority
MX
Mexico
Prior art keywords
bifidobacterium
organisms
present
probiotics
boosting effect
Prior art date
Application number
MX2011012069A
Other languages
English (en)
Inventor
Guenolee Prioult
Annick Mercenier
Sophie Nutten
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40848602&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2011012069(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2011012069A publication Critical patent/MX2011012069A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Dairy Products (AREA)

Abstract

La presente invención se refiere de manera general al campo de las bacterias probióticas. En particular, la presente invención se refiere probióticos no-replicantes, tales como el género Lactobacillus, Bifidobacterium o combinaciones de los mismos, por ejemplo Lactobacillus paracasei, Lactobacillus rhamnosus, Bifidobacterium Ion gum, Bifidobacterium lactis, Bifidobacterium breve o combinaciones de as mismas, y aplicaciones de estas bacterias. Una modalidad de la presente invención se refiere a probióticos no-replicantes y su uso para preparar una composición para tratar o prevenir padecimientos relacionados con una defensa inmune comprometida. Se describe un método para incrementar la efectividad de los probióticos para tratar o prevenir padecimientos inmunes.
MX2011012069A 2009-05-11 2010-05-07 Micro-organismos no-replicantes y su efecto inmuno estimulador. MX2011012069A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09159929A EP2251022A1 (en) 2009-05-11 2009-05-11 Non-replicating micro-organisms and their immune boosting effect
PCT/EP2010/056287 WO2010130660A1 (en) 2009-05-11 2010-05-07 Non-replicating micro-organisms and their immune boosting effect

Publications (1)

Publication Number Publication Date
MX2011012069A true MX2011012069A (es) 2011-12-06

Family

ID=40848602

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011012069A MX2011012069A (es) 2009-05-11 2010-05-07 Micro-organismos no-replicantes y su efecto inmuno estimulador.

Country Status (14)

Country Link
US (1) US20120107290A1 (es)
EP (2) EP2251022A1 (es)
JP (1) JP2012526749A (es)
CN (1) CN102724987A (es)
AR (1) AR076862A1 (es)
AU (1) AU2010247467A1 (es)
BR (1) BRPI1011024A2 (es)
CA (1) CA2761442A1 (es)
CL (1) CL2011002852A1 (es)
MX (1) MX2011012069A (es)
RU (1) RU2011150187A (es)
TW (1) TW201103552A (es)
WO (1) WO2010130660A1 (es)
ZA (1) ZA201109087B (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1012849A2 (pt) 2009-05-11 2018-06-19 Nestec Sa lactobacillus johnsonii la1 ncc533 (cncm i-1225) e distúrbios imunes
TWI406665B (zh) * 2010-09-01 2013-09-01 Genmont Biotech Inc 益生菌株ｇｍ－０８０用於製備治療心臟發炎與心臟細胞凋亡之醫藥組合物及其用途
EP2455094A1 (en) * 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect children against gastrointestinal infections
EP2455093A1 (en) * 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic bacteria and prevention or treatment of infections in children
BR112013020312B1 (pt) * 2011-02-09 2021-03-23 Synbiotics Ab Composições simbióticas para restauração e reconstituição da microbiota intestinal
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
WO2014083166A1 (en) * 2012-11-29 2014-06-05 Nestec S.A. Synbiotic composition and use thereof
US20150313952A1 (en) * 2012-11-29 2015-11-05 Nestec S.A. Synbiotic composition and use thereof
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
KR101640744B1 (ko) 2014-05-07 2016-07-19 일동제약주식회사 고분자 다당 바인더에 컨쥬게이트된 락토바실러스 람노서스 rht-3201, 및 이의 아토피 예방 및 치료 용도
HUE037476T2 (hu) 2014-12-23 2018-08-28 4D Pharma Res Ltd Pirin polipeptid és immunmodulálás
PE20171138A1 (es) 2014-12-23 2017-08-09 4D Pharma Res Ltd Modulacion inmunitaria
EA038405B1 (ru) 2015-06-15 2021-08-24 4Д Фарма Рисёрч Лимитед ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ШТАММЫ БАКТЕРИИ Bifidobacterium breve, ДЛЯ ЛЕЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ ЗАБОЛЕВАНИЯ ИЛИ ПАТОЛОГИЧЕСКОГО СОСТОЯНИЯ, ОПОСРЕДОВАННОГО IL-17 ИЛИ Th17
TW202223083A (zh) 2015-06-15 2022-06-16 英商4D製藥研究有限公司 包含細菌菌株之組合物之用途
RS59308B1 (sr) 2015-06-15 2019-10-31 4D Pharma Res Ltd Kompozicije koje sadrže bakterijske sojeve
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
CN108289919A (zh) * 2015-10-19 2018-07-17 株式会社明治 面向婴儿的抗过敏剂
SG11201803275UA (en) * 2015-10-19 2018-05-30 Meiji Co Ltd Infection protective agent for infants
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
PT3209310T (pt) 2015-11-20 2018-04-20 4D Pharma Res Ltd Composições compreendendo estirpes bacterianas
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
TW201733601A (zh) 2016-03-04 2017-10-01 ４Ｄ製藥有限公司 包含細菌菌株之組合物
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
WO2017173241A1 (en) 2016-03-31 2017-10-05 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
AU2017240068B2 (en) 2016-03-31 2022-12-15 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
TW201821093A (zh) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
ES2657665B1 (es) * 2016-09-05 2018-12-17 Pedro Jose DE LA FUENTE BLASCO Productos para la salud con probióticos inactivados y uso de dichos productos
JP2020500860A (ja) 2016-11-23 2020-01-16 ゴジョ・インダストリーズ・インコーポレイテッド プロバイオティック／プレバイオティックな有効成分を含む消毒薬組成物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
MA48939B1 (fr) 2017-05-22 2021-06-30 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
JP6978514B2 (ja) 2017-05-24 2021-12-08 フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited 細菌株を含む組成物
CN107114794A (zh) * 2017-06-06 2017-09-01 上海真合生物技术有限公司 用于增强抗过敏能力的益生菌组合物
TW201919670A (zh) 2017-06-14 2019-06-01 英商4D製藥研究有限公司 包含細菌品系之組成物
DK3600363T3 (da) 2017-06-14 2021-01-25 4D Pharma Res Ltd Sammensætninger omfattende bakteriestammer
CA3066557A1 (en) 2017-06-14 2018-12-20 4D Pharma Research Limited Compositions comprising bacterial strains
JP2019208486A (ja) * 2018-06-08 2019-12-12 株式会社ブロマ研究所 乳酸菌含有組成物及び免疫賦活用組成物
US20210268041A1 (en) * 2018-06-22 2021-09-02 Synformulas Gmbh Non-viable bifidobacterium bifidum bacteria and uses thereof
US11497197B2 (en) * 2018-07-18 2022-11-15 University Of Connecticut Methods for enhancing poultry growth and performance
KR20230119213A (ko) * 2020-12-17 2023-08-16 신발란스 에스알엘 프로바이오틱 조성물 및 스트레스-관련 병태의 예방및/또는 치료에서 이의 용도

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1110555A1 (fr) * 1999-12-22 2001-06-27 Societe Des Produits Nestle S.A. Agent anti-adhesion de la flore pathogene de la peau
ES2378811T3 (es) * 2000-01-18 2012-04-18 Societe des Produits Nestlé S.A. Composiciones de alimento para mascotas que permiten tratar a los animales domésticos contra especies de helicobacter
JP4510376B2 (ja) * 2000-10-06 2010-07-21 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 皮膚の免疫系のバランスを保つためのプロバイオティック乳酸菌の使用
US20050180962A1 (en) * 2003-01-30 2005-08-18 Eyal Raz Inactivated probiotic bacteria and methods of use thereof
CA2557834C (en) * 2004-03-04 2012-05-22 E-L Management Corporation Skin treatment method with lactobacillus extract
JP5371169B2 (ja) * 2004-09-24 2013-12-18 コンビ株式会社 薬剤耐性菌感染防除剤
KR100578395B1 (ko) * 2005-11-11 2006-05-10 주식회사 바이오리더스 면역기능이 강화된 사균화 유산균 제제 및 그 제조방법
RU2445362C2 (ru) * 2006-02-15 2012-03-20 Нестек С.А. Применение bifidobacterium longum в производстве лекарственного средства или терапевтической питательной композиции для лечения воспалительного заболевания кишечника у млекопитающего и для ослабления воспаления кишечника, связанного с пищевыми аллергенами, у млекопитающего
MX2009008875A (es) * 2007-02-28 2009-08-28 Mead Johnson Nutrition Co Producto que contiene probiotico inactivado para niños o infantes.
JP2008245569A (ja) * 2007-03-30 2008-10-16 Kirin Holdings Co Ltd 高抗アレルギー活性を有する乳酸菌組成物及び該乳酸菌の製造方法
ES2578261T3 (es) * 2007-05-18 2016-07-22 Nestec S.A. Lactobacillus johnsonii para prevenir infecciones postoperatorias
WO2008153377A1 (en) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
EP2022502A1 (en) * 2007-08-10 2009-02-11 Nestec S.A. Lactobacillus rhamnosus and weight control

Also Published As

Publication number Publication date
CL2011002852A1 (es) 2012-07-20
AU2010247467A1 (en) 2011-12-08
AR076862A1 (es) 2011-07-13
RU2011150187A (ru) 2013-06-20
CA2761442A1 (en) 2010-11-18
TW201103552A (en) 2011-02-01
EP2429547A1 (en) 2012-03-21
JP2012526749A (ja) 2012-11-01
US20120107290A1 (en) 2012-05-03
CN102724987A (zh) 2012-10-10
EP2251022A1 (en) 2010-11-17
BRPI1011024A2 (pt) 2019-09-24
WO2010130660A1 (en) 2010-11-18
ZA201109087B (en) 2013-05-29

Similar Documents

Publication Publication Date Title
MX2011012069A (es) Micro-organismos no-replicantes y su efecto inmuno estimulador.
UA111715C2 (uk) Композиція, що містить пробіотичні бактерії для застосування у лікуванні імунних розладів
NZ593708A (en) Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin
MY193275A (en) Use of probiotics in the treatment and/or prevention of psoriasis
PH12019500123A1 (en) Use of probiotics in the treatment and/or prevention of atopic dermatitis
MY159273A (en) Bifidobacterium longum ncc2705 (cncm i-2618) and immune disorders
MX2012002402A (es) Bifidobacterium longum y trastornos gastrointestinales funcionales.
AR035761A1 (es) Bacterias de acido lactico como agentes para tratar y prevenir la alergia
HRP20130487A2 (hr) Formulacija probiotika s apigeninom i ekstraktom paprene metvice
ZA201804863B (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
WO2007023226A3 (fr) Utilisation d'un symbiotique pour le traitement de la dermatite atopique
ATE541468T1 (de) Mikrobielle futterergänzungsmittel und verwendungen davon in verfahren zur verringerung und/oder verhinderung von azidose in polygastrischen pflanzenfressern
UA94056C2 (uk) Застосування специфічних молочнокислих бактерій для одержання імуномодулюючих композицій
PH12023550118A1 (en) Lactobacillus salivarus strain and its use in the prevention and treatment of urogenital tract dysbiosis
WO2008002484A3 (en) Novel lactobacillus bulgaricus strain and compositions
PL406051A1 (pl) Zastosowanie kompozycji probiotycznej
Khursigara Sticking it to the gut: Promoting probiotic biofilm development
BG110152A (en) PROBIOTICALLY LACTOBACILLUS DELBRUECKII SUBSP. BULGARICUS
LT2013502A (lt) Maistinio arba farmacinio biopreparato kompozicija
AR061534A1 (es) Procedimiento para eliminar salmonella de materia prima derivada de poroto de soja y composicion salmonellicida util en dicho procedimiento
UA89037U (uk) Кормова добавка з пробіотичною дією "пробіолакт"
HK40000927A (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
PL397178A1 (pl) Kompozycja probiotyczna
UA116253C2 (uk) Спосіб одержання бактеріального концентрату "бк-птиця" для кормових продуктів
GEU20111671Y (en) Probiotic preparation having capsule form

Legal Events

Date Code Title Description
FA Abandonment or withdrawal